BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15079813)

  • 1. S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts.
    Remppis A; Pleger ST; Most P; Lindenkamp J; Ehlermann P; Schweda C; Löffler E; Weichenhan D; Zimmermann W; Eschenhagen T; Koch WJ; Katus HA
    J Gene Med; 2004 Apr; 6(4):387-94. PubMed ID: 15079813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A1 gene transfer in myocardium.
    Pleger ST; Most P; Heidt B; Voelkers M; Hata JA; Katus HA; Remppis A; Koch WJ
    Eur J Med Res; 2006 Oct; 11(10):418-22. PubMed ID: 17107875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.
    Pleger ST; Remppis A; Heidt B; Völkers M; Chuprun JK; Kuhn M; Zhou RH; Gao E; Szabo G; Weichenhan D; Müller OJ; Eckhart AD; Katus HA; Koch WJ; Most P
    Mol Ther; 2005 Dec; 12(6):1120-9. PubMed ID: 16168714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-delivered short hairpin RNA targeting PKCalpha improves contractile function in reconstituted heart tissue.
    El-Armouche A; Singh J; Naito H; Wittköpper K; Didié M; Laatsch A; Zimmermann WH; Eschenhagen T
    J Mol Cell Cardiol; 2007 Sep; 43(3):371-6. PubMed ID: 17628588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium.
    Most P; Pleger ST; Völkers M; Heidt B; Boerries M; Weichenhan D; Löffler E; Janssen PM; Eckhart AD; Martini J; Williams ML; Katus HA; Remppis A; Koch WJ
    J Clin Invest; 2004 Dec; 114(11):1550-63. PubMed ID: 15578088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of sorcin enhances cardiac contractility in vivo and in vitro.
    Frank KF; Bölck B; Ding Z; Krause D; Hattebuhr N; Malik A; Brixius K; Hajjar RJ; Schrader J; Schwinger RH
    J Mol Cell Cardiol; 2005 Apr; 38(4):607-15. PubMed ID: 15808837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
    Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T
    J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A1: a regulator of myocardial contractility.
    Most P; Bernotat J; Ehlermann P; Pleger ST; Reppel M; Börries M; Niroomand F; Pieske B; Janssen PM; Eschenhagen T; Karczewski P; Smith GL; Koch WJ; Katus HA; Remppis A
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13889-94. PubMed ID: 11717446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac grafting of engineered heart tissue in syngenic rats.
    Zimmermann WH; Didié M; Wasmeier GH; Nixdorff U; Hess A; Melnychenko I; Boy O; Neuhuber WL; Weyand M; Eschenhagen T
    Circulation; 2002 Sep; 106(12 Suppl 1):I151-7. PubMed ID: 12354725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes.
    Zimmermann WH; Fink C; Kralisch D; Remmers U; Weil J; Eschenhagen T
    Biotechnol Bioeng; 2000 Apr; 68(1):106-14. PubMed ID: 10699878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a biological ventricular assist device: preliminary data from a small animal model.
    Yildirim Y; Naito H; Didié M; Karikkineth BC; Biermann D; Eschenhagen T; Zimmermann WH
    Circulation; 2007 Sep; 116(11 Suppl):I16-23. PubMed ID: 17846298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle.
    Naito H; Melnychenko I; Didié M; Schneiderbanger K; Schubert P; Rosenkranz S; Eschenhagen T; Zimmermann WH
    Circulation; 2006 Jul; 114(1 Suppl):I72-8. PubMed ID: 16820649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac transgenic and gene transfer strategies converge to support an important role for troponin I in regulating relaxation in cardiac myocytes.
    Yasuda S; Coutu P; Sadayappan S; Robbins J; Metzger JM
    Circ Res; 2007 Aug; 101(4):377-86. PubMed ID: 17615373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes.
    Kettlewell S; Most P; Currie S; Koch WJ; Smith GL
    J Mol Cell Cardiol; 2005 Dec; 39(6):900-10. PubMed ID: 16236309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.
    Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ
    Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance.
    Most P; Remppis A; Pleger ST; Löffler E; Ehlermann P; Bernotat J; Kleuss C; Heierhorst J; Ruiz P; Witt H; Karczewski P; Mao L; Rockman HA; Duncan SJ; Katus HA; Koch WJ
    J Biol Chem; 2003 Sep; 278(36):33809-17. PubMed ID: 12777394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes.
    Most P; Boerries M; Eicher C; Schweda C; Völkers M; Wedel T; Söllner S; Katus HA; Remppis A; Aebi U; Koch WJ; Schoenenberger CA
    J Cell Sci; 2005 Jan; 118(Pt 2):421-31. PubMed ID: 15654019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue.
    Pleger ST; Most P; Boucher M; Soltys S; Chuprun JK; Pleger W; Gao E; Dasgupta A; Rengo G; Remppis A; Katus HA; Eckhart AD; Rabinowitz JE; Koch WJ
    Circulation; 2007 May; 115(19):2506-15. PubMed ID: 17470693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.
    Zimmermann WH; Melnychenko I; Wasmeier G; Didié M; Naito H; Nixdorff U; Hess A; Budinsky L; Brune K; Michaelis B; Dhein S; Schwoerer A; Ehmke H; Eschenhagen T
    Nat Med; 2006 Apr; 12(4):452-8. PubMed ID: 16582915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.